Toklu Hale Z, Sehirli A Ozer, Velioğlu-Oğünç Ayliz, Cetinel Sule, Sener Göksel
Marmara University, School of Pharmacy, Department of Pharmacology, Istanbul, Turkey.
Eur J Pharmacol. 2006 Aug 14;543(1-3):133-40. doi: 10.1016/j.ejphar.2006.05.033. Epub 2006 Jun 2.
The protective effect of beta-glucan against oxidative injury caused by acetaminophen was studied in mice liver. BALB-c mice (25-30 g) were pre-treated with beta-d-glucan (50 mg/kg, p.o.) for 10 days and on the 11th day they received an overdose of acetaminophen (900 mg/kg, i.p.). Four hours after the acetaminophen injection, mice were decapitated and their blood was taken to determine serum aspartate aminotransferase (AST), alanine aminotransferase (ALT), lactate dehydrogenase (LDH) and tumor necrosis factor-alpha (TNF-alpha) levels. Tissue samples of the liver were taken for histological examination or for the determination of levels of malondialdehyde, an end product of lipid peroxidation; glutathione (GSH), a key antioxidant; and myeloperoxidase activity, an index of tissue neutrophil infiltration. The formation of reactive oxygen species in hepatic tissue samples was monitored by using the chemiluminescence technique with luminol and lucigenin probes. Acetaminophen caused a significant decrease in the GSH level of the tissue, which was accompanied with significant increases in the hepatic luminol and lucigenin chemiluminescence values, malondialdehyde level, MPO activity and collagen content. Similarly, serum ALT, AST levels, as well as LDH and TNF-alpha, were elevated in the acetaminophen-treated group when compared with the control group. On the other hand, beta-d-glucan treatment reversed all these biochemical indices, as well as histopathological alterations that were induced by acetaminophen. In conclusion, these results suggest that beta-d-glucan exerts cytoprotective effects against oxidative injury through its antioxidant properties and may be of therapeutic use in preventing acetaminophen toxicity.
在小鼠肝脏中研究了β-葡聚糖对乙酰氨基酚所致氧化损伤的保护作用。将BALB-c小鼠(25 - 30克)用β-d-葡聚糖(50毫克/千克,口服)预处理10天,在第11天给予过量的乙酰氨基酚(900毫克/千克,腹腔注射)。乙酰氨基酚注射4小时后,将小鼠断头并取血以测定血清天冬氨酸转氨酶(AST)、丙氨酸转氨酶(ALT)、乳酸脱氢酶(LDH)和肿瘤坏死因子-α(TNF-α)水平。取肝脏组织样本进行组织学检查或测定脂质过氧化终产物丙二醛的水平;关键抗氧化剂谷胱甘肽(GSH);以及髓过氧化物酶活性,这是组织中性粒细胞浸润的指标。通过使用鲁米诺和光泽精探针的化学发光技术监测肝组织样本中活性氧的形成。乙酰氨基酚导致组织中GSH水平显著降低,同时伴有肝脏鲁米诺和光泽精化学发光值、丙二醛水平、MPO活性和胶原蛋白含量显著增加。同样,与对照组相比,乙酰氨基酚治疗组的血清ALT、AST水平以及LDH和TNF-α均升高。另一方面,β-d-葡聚糖治疗逆转了所有这些生化指标以及由乙酰氨基酚诱导的组织病理学改变。总之,这些结果表明β-d-葡聚糖通过其抗氧化特性对氧化损伤发挥细胞保护作用,并且可能在预防乙酰氨基酚毒性方面具有治疗用途。